-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Carisma Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2015 to Q2 2024.
- Carisma Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 41.5M shares, a 3.19% increase year-over-year.
- Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 33.5M shares, a 1475% increase from 2022.
- Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 2.13M shares, a 98.8% decline from 2021.
- Carisma Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 182M shares, a 54.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)